Search research articles
Contact Us
Filters
Showing results (41-50 of 125) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
August 16, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Katrina Piedra, Tim Peterson, Carlyn Tan, et al.
British Journal of Haematology
|
February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
Marion Eveillard, Even Rustad, Mikhail Roshal, et al.
Leukemia & Lymphoma
|
December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility study
Sham Mailankody, Sean M Devlin, Neha Korde, et al.
Leukemia & Lymphoma
|
October 14, 2016
Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency
Adebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Thrombosis Research
|
December 14, 2002
Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants
Sarah E Michaud, Louise Z Wang, Neha Korde, et al.
Leukemia & Lymphoma
|
May 26, 2017
Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
Dalia Abdel-Raouf Salem, Neha Korde, David J Venzon, et al.
Blood Advances
|
January 4, 2018
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
British Journal of Haematology
|
March 22, 2016
Monoclonal gammopathy-associated pure red cell aplasia
Neha Korde, Yong Zhang, Kelsey Loeliger, et al.
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 125) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
August 16, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis
Katrina Piedra, Tim Peterson, Carlyn Tan, et al.
British Journal of Haematology
|
February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myeloma
Marion Eveillard, Even Rustad, Mikhail Roshal, et al.
Leukemia & Lymphoma
|
December 3, 2016
Proteomic profiling in plasma cell disorders: a feasibility study
Sham Mailankody, Sean M Devlin, Neha Korde, et al.
Leukemia & Lymphoma
|
October 14, 2016
Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: efficacy and analysis of risk factors associated with poor stem cell collection efficiency
Adebayo Ogunniyi, Mabel Rodriguez, Sean Devlin, et al.
Haematologica
|
September 3, 2021
Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls
Urvi A Shah, Sæmundur Rögnvaldsson, Andriy Derkach, et al.
Thrombosis Research
|
December 14, 2002
Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants
Sarah E Michaud, Louise Z Wang, Neha Korde, et al.
Leukemia & Lymphoma
|
May 26, 2017
Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma
Dalia Abdel-Raouf Salem, Neha Korde, David J Venzon, et al.
Blood Advances
|
January 4, 2018
Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
Marianna Thordardottir, Ebba K Lindqvist, Sigrun H Lund, et al.
British Journal of Haematology
|
March 22, 2016
Monoclonal gammopathy-associated pure red cell aplasia
Neha Korde, Yong Zhang, Kelsey Loeliger, et al.
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
Page
of 13